A critical discovery in cancer study is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in many types of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research